Current diabetes and metabolic health news selected for patient safety, public usefulness, novelty, and evidence strength.News posts summarize source material in plain language and include practical takeaways. They are not individualized medical advice and should not replace clinician guidance.
An analysis of 87 randomized trials found modest improvements in cholesterol, blood pressure and glucose with more whole grains. Here is what it means.
FDA testing found toxic yellow oleander in several products marketed for weight loss and undeclared sibutramine in LUZE Fit Intensity. Here is what consumers should do.
An 18-month randomized trial found that an interactive digital programme helped adults reduce sugary drinks and achieve modest weight loss compared with standard online education.
New Look AHEAD findings connect IL-6 with heart-failure risk in type 2 diabetes, but do not support routine testing. Here is what patients should know.
A small trial compared keto, Mediterranean and plant-forward diets for fatty liver. Understand the findings, limitations and diabetes medication precautions.
The FDA has authorized Libre Duo 10 Day for people aged 2 and older with diabetes. Here is how combined continuous glucose and ketone monitoring works, what the evidence shows, and the DKA safety limits patients should understand.
